Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BianoScience

BianoScience?uq=ucpGzW8d
2011 FOUNDED
PRIVATE STATUS
PE Growth LATEST DEAL TYPE
2 INVESTORS
Description

Manufacturer of DNA- and RNA-based drugs under Good Manufacturing Practice on behalf of drug developers. The company offers small to medium scale cGMP- and ISO9001 certified oligonucleotide synthesis facility for clinical oligonucleotide applications starting from 50g to multiple grams.

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
  • Dieselstraße 26
  • 08058 Zwickau
  • Germany

+49 0375 0000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore BianoScience’s full profile, request a free trial.

BianoScience Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. PE Growth/Expansion 29-Mar-2018 Completed Generating Revenue
1. Early Stage VC Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

BianoScience Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Beteiligungsmanagement Thuringen PE/Buyout Minority 000 0000 000000 0
TechnologieContor Venture Capital Minority 000 0000 000000 0

BianoScience Executive Team (2)

Name Title Board
Seat
Contact
Info
Tobias Pöhlmann Ph.D Founder & Managing Director
Rolf Gunther Ph.D Managing Director